Streetbeat News

Stock Prices

ON

ON Semiconductor (NASDAQ:ON) has significantly outperformed the market over the past decade, with an annualized return of 23.05%. A $100 investment 10 years ago would now be worth $803.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 8:30 pm

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has significantly outperformed the market over the past 20 years, with an annualized return of 27.55%. A $1000 investment in REGN 20 years ago would be worth $132,765.03 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 8:30 pm

ACB

EAST

GNLN

GRWG

MXC

SNDL

SOL

TLRY

UGRO

XXII

On August 20, 2024, several marijuana-related stocks experienced significant price movements. Notable gainers included Flowr, Pharmadrug, and Global Hemp Group, while significant losers included Blueberries Medical, Body and Mind, and MariMed. Emeren Group and Mexco Energy also saw notable gains.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 8:30 pm

KEYS

Keysight Technologies' stock rose after the company reported better-than-expected Q3 earnings and revenue. The company posted an EPS of $1.57, beating estimates by 16.3%, and revenue of $1.22 billion, surpassing expectations by 2.17%. Despite declines in certain segments, the company remains optimistic about future orders.

Portfolio Pulse from Erica Kollmann

August 20, 2024 | 8:29 pm

PAGS

PegSeguro Digital shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:27 pm

FWONK

Liberty Media's stock is declining following the announcement of a public offering of 10.65 million shares of Series C common stock.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:26 pm

MCHP

Microchip Technology is investigating a suspicious IT activity incident and has not yet determined if it will materially impact their financial condition or operations.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:22 pm

AZTR

Azitra shares rose following the announcement of the first patient screening in its Phase 1b clinical trial for ATR-12, aimed at treating Netherton syndrome.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:19 pm

DDD

3D Systems reported a significant miss in both earnings and sales for Q1, with an adjusted EPS of $(0.17) against an expected $(0.04), and sales of $102.91M against an expected $117.39M. This represents a substantial decline from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:19 pm

LZB

La-Z-Boy shares declined following the release of Q1 earnings and Q2 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:19 pm